Zsírmáj (MASLD/MASH): vizsgálatok itt: Svájc
12 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- Where
- Bern, Olten, Sankt Gallen
- Életkor
- 18 év to 80 év
- People
- 1650 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06215716 - 3. fázisTaking peopleLIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Where
- Arzo, Bern, Geneva, Zurich
- Életkor
- 18 év and over
- People
- 1800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632444 · EU 2024-513739-25-00 - 3. fázisTaking peopleLIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Where
- Arzo, Geneva, Zurich
- Életkor
- 18 év and over
- People
- 1590 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00 - 3. fázisTaking peopleA Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Where
- Bern, Lugano, Olten, Sankt Gallen, Zurich
- Életkor
- 18 év to 80 év
- People
- 2150 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06528314 - 3. fázisTaking peopleA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Where
- Basel, Olten
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07165028 · EU 2025-522674-36-00 - No phaseNot yet taking people in SvájcGLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
- Where
- Bern
- Életkor
- 18 év to 80 év
- People
- 64
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT06546384 - 4. fázisTaking peopleFibrosis Lessens After Metabolic Surgery
- Where
- Basel, Geneva
- Életkor
- 18 év to 75 év
- People
- 120 worldwide
- Run by
- The Cleveland Clinic
See details and how to joinNCT06374875 - No phaseTaking peopleProspective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease
- Where
- Lugano
- Életkor
- 18 év and over
- People
- 300
- Run by
- Fondazione Epatocentro Ticino
See details and how to joinNCT07051863 - No phaseTaking peopleThe Development of MASLD Among Survivors of Breast or Colorectal Cancer
- Where
- Bern
- Életkor
- 18 év and over
- People
- 200
- Run by
- University of Bern
See details and how to joinNCT07280143 - No phaseTaking peopleIdentification of Hepatic Fibrosis Using 4D-MRI
- Where
- Basel, Liestal
- Életkor
- 18 év and over
- People
- 200
- Run by
- University Hospital, Basel, Switzerland
See details and how to joinNCT05385237 - No phaseTaking peopleThe European NAFLD Registry
- Where
- Bern
- Életkor
- 18 év to 100 év
- People
- 10 000 worldwide
- Run by
- Newcastle University
See details and how to joinNCT04442334 - No phaseTaking peopleProspective Cohort Study in Patients With NAFLD
- Where
- Zurich
- Életkor
- 18 év and over
- People
- 150
- Run by
- University of Zurich
See details and how to joinNCT00575133